Compounds > cytarabine

cytarabine and cabozantinib

cytarabine has been researched along with cabozantinib in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chien, HF; Hu, CY; Ko, YC; Lin, LI; Liu, ZH; Ou, DL; Tien, HF1
He, R; Li, J; Liu, X; Pan, R; Wang, C1

Other Studies

2 other study(ies) available for cytarabine and cabozantinib

ArticleYear
Cytarabine-Resistant
    International journal of molecular sciences, 2019, Mar-11, Volume: 20, Issue:5

    Topics: Anilides; Apoptosis Regulatory Proteins; Biomarkers; Cell Line, Tumor; Cell Survival; Cytarabine; DNA Mutational Analysis; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; fms-Like Tyrosine Kinase 3; Gene Deletion; Humans; Leukemia, Myeloid, Acute; Metabolic Networks and Pathways; Mutation; Pyridines; Tandem Repeat Sequences; Tumor Suppressor Protein p53

2019
Prenylation-dependent Ras inhibition by pamidronate inhibits pediatric acute myeloid leukemia stem and differentiated cell growth and survival.
    Biochemical and biophysical research communications, 2019, 09-24, Volume: 517, Issue:3

    Topics: Anilides; Annexin A5; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzothiazoles; Bone Density Conservation Agents; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Child; Cytarabine; Daunorubicin; Drug Repositioning; Humans; Leukemia, Myeloid, Acute; Neoplastic Stem Cells; Pamidronate; Phenylurea Compounds; Primary Cell Culture; Protein Prenylation; Protein Processing, Post-Translational; Pyridines; ras Proteins

2019